600079.SS Stock Analysis
60
Avoid
Based on Eyestock quantitative analysis, 600079.SS`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Undervalued
Market cap $B
4.294
Dividend yield
2.61 %
Shares outstanding
1 620.72 B
Website
http://www.humanwell.com.cnHumanwell Healthcare (Group) Co., Ltd. engages in the research and development, production, and sale of medical products. The company is headquartered in Wuhan, Hubei and currently employs 15,746 full-time employees. The Company’s products are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines and others. The firm also provides medical instruments. The firm distributes its products in both domestic market and to overseas markets.